Skip to main content
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

Expert opinion on the G-BA Innovation Fund recommends continuing the Fund permanently in Germany

18 May 2022

On April 19, 2022, the Innovation Committee at the Federal Joint Committee (G-BA) has informed of the favorable results of the scientific evaluation of the G-BA Innovation Fund performed by the economic research center Prognos AG.

In the final report that analyzed the work of the Innovation Fund in 2019-2021, it is concluded that the work results are considered successful with appropriate use of funds and transparent communication. Projects funded by the Innovation Fund can be used to gain the reliable knowledge required for the further development of healthcare within the statutory health insurance system.

This report supports the plans of the government coalition parties to establish the Innovation Fund permanently (currently, the Innovation Fund is extended until 2024). The development of the report was commissioned by the Federal Ministry of Health.

The full details in German can be found here and here (Prognos final report).

This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news).

Not ready for a subscription service? Subscribe to our free-of-charge newsletter delivered every second week to get updates about key reimbursement developments in Europe (10-12 news every two weeks). First EU issues of both newsletters are available for download free-of-charge.